For example, ALK mutations are frequently observed in MYCN-amplified neuroblastomas, and most of ALK amplifications co-occur with MYCN amplification (George et al., 2008; Bresler et al., 2014; Bagci et al., 2012; De Brouwer et al., 2010). The gene discussed is ALK; the disease is neuroblastoma.